Caitlin Zarick
Foot & Ankle Surgery · Washington, DCNPI 1760777072
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.0%), education and other — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 32.6% of the total. Reporting peaked in 2023 at $1,845 and has fallen 92.7% since, to $134 in 2025.
Across 61 payments — averaging $86.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$2K
- Integra Lifesciences Corporation$2K
- Stryker$1K
- Smith+Nephew$422
- Fusion Orthopedics USA, LLC$87
- Mimedx Group, Inc.$45
- plus $82 from 4 others
What the payments were for
- Food & beverage$2,09940%
- Education$1,70032%
- Other$1,44828%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 3 | $1,712 |
| Integra Lifesciences Corporation | 6 | $1,533 |
| Stryker(2 entities) | 24 | $1,366 |
| Smith+Nephew | 21 | $422 |
| Fusion Orthopedics USA, LLC | 1 | $87 |
| Mimedx Group, Inc. | 2 | $45 |
| Johnson & Johnson | 1 | $28 |
| Bioventus LLC | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| TELA Bio, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$1,448
- HOFFMANN$260
- PROPHECY$161
- AUGMENT INJECTABLE$148
- ASNIS$108
How this compares
$5,247 in reported general payments places this provider in the 55th percentile of 23 foot & ankle surgery providers in District of Columbia.
See all foot & ankle surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 46 | $1,180 |
| Diclofenac Sodium | 31 | $956 |
| Clotrimazole | 24 | $428 |
| Meloxicam | 33 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Washington
- Paul CooperWashington$186K
- John SteinbergWashington$166K
- Ali Rahnama VaghefWashington$132K
- Jayson AtvesWashington$24K
- Shelton McKenzieWashington$22K
- Bilal LouzatiWashington$18K
- Ali QadriWashington$17K
- Alex MattiaWashington$13K
- Emily DurranceWashington$9K
- Selin RuggieriWashington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.